Abstract
This paper presents a novel approach to improving text-based cancer data classification by integrating BERTopic clustering with Support Vector Machine (SVM) classifiers, combined with the Explainable Inconsistency Algorithm (EIA). The proposed method leverages advanced preprocessing techniques, including Node2Vec embeddings, to enhance both clustering and classification performance. Through the introduction of EIA, we automatically identify and eliminate outliers and discordant data points, thus improving classification accuracy and providing valuable insights into underlying data relation-ships. A key innovation in this work is the use of recommender systems for mapping clusters to labels, which improves label assignment through collaborative filtering techniques. Our experimental results show a significant increase in both accuracy and F1-score after addressing data inconsistencies, with improvements validated through statistical tests, including t-tests. This paper contributes a robust, explainable, and scalable framework for cancer data analysis, offering potential applications in other domains requiring high-precision text classification. Future work will focus on extending the EIA to other biomedical datasets, optimizing hyperparameters, and deploying the framework in real-time clinical decision-support systems.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
pmortezaagha{at}ohri.ca
arahgozar{at}toh.ca
Data Availability
All data produced in the present work are contained in the manuscript